[go: up one dir, main page]

MX2019008051A - Composiciones polimericas reticulables in-situ y metodos de las mismas. - Google Patents

Composiciones polimericas reticulables in-situ y metodos de las mismas.

Info

Publication number
MX2019008051A
MX2019008051A MX2019008051A MX2019008051A MX2019008051A MX 2019008051 A MX2019008051 A MX 2019008051A MX 2019008051 A MX2019008051 A MX 2019008051A MX 2019008051 A MX2019008051 A MX 2019008051A MX 2019008051 A MX2019008051 A MX 2019008051A
Authority
MX
Mexico
Prior art keywords
cross
methods
polymeric composition
wound
linking
Prior art date
Application number
MX2019008051A
Other languages
English (en)
Inventor
A Landolina Joseph
Original Assignee
Cresilon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cresilon Inc filed Critical Cresilon Inc
Publication of MX2019008051A publication Critical patent/MX2019008051A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F283/00—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Dental Preparations (AREA)

Abstract

Se describe una composición polimérica para reticulado in situ en una herida que comprende 1) uno o más polímeros polianiónicos como los alginatos o hialuronatos capaces de ser reticulados en la superficie de una herida y 2) uno o más polímeros policatiónicos como el quitosán o Dextrano-DEAE que ayuda en el proceso de solidificación y acelera la hemostasis sin necesidad de ejercer presión. La composición polimérica biocompatíble puede comprender un agente reticulante como el cloruro de calcio acuoso. La invención abarca una composición polimérica inicial, la matriz solidificada reticulada e integrada a la zona de la herida, incluyendo los métodos de uso, aplicación y reticulación de la composición.
MX2019008051A 2011-11-13 2014-05-12 Composiciones polimericas reticulables in-situ y metodos de las mismas. MX2019008051A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161559110P 2011-11-13 2011-11-13

Publications (1)

Publication Number Publication Date
MX2019008051A true MX2019008051A (es) 2019-09-09

Family

ID=48290658

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014005738A MX366366B (es) 2011-11-13 2012-11-12 Composiciones polimericas reticulables in-situ y metodos de las mismas.
MX2019008051A MX2019008051A (es) 2011-11-13 2014-05-12 Composiciones polimericas reticulables in-situ y metodos de las mismas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2014005738A MX366366B (es) 2011-11-13 2012-11-12 Composiciones polimericas reticulables in-situ y metodos de las mismas.

Country Status (16)

Country Link
US (4) US20140287061A1 (es)
EP (1) EP2776068A4 (es)
JP (3) JP2014533181A (es)
KR (1) KR20140090670A (es)
CN (2) CN109602944A (es)
AU (2) AU2012334982A1 (es)
BR (1) BR112014011442A8 (es)
CA (1) CA2855347C (es)
HK (1) HK1201734A1 (es)
IL (1) IL232330B (es)
IN (1) IN2014CN03524A (es)
MX (2) MX366366B (es)
RU (2) RU2640084C2 (es)
SG (2) SG11201402279SA (es)
WO (1) WO2013071235A1 (es)
ZA (1) ZA201403166B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008348311B2 (en) 2008-01-24 2014-06-26 University Of Utah Research Foundation Adhesive complex coacervates and methods of making and using thereof
US8283384B2 (en) 2008-01-24 2012-10-09 University Of Utah Research Foundation Adhesive complex coacervates and methods of making and using thereof
CA2799818A1 (en) 2010-05-24 2011-12-01 University Of Utah Research Foundation Reinforced adhesive complex coacervates and methods of making and using thereof
JP2014502296A (ja) 2010-11-12 2014-01-30 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション 単純接着剤コアセルベートならびにその製造方法および使用
CN109602944A (zh) 2011-11-13 2019-04-12 克里斯龙公司 原位可交联的聚合物组合物及其方法
WO2014123665A1 (en) 2013-02-06 2014-08-14 Kci Licensing, Inc. Polymers, preparation and use thereof
ITTO20130375A1 (it) * 2013-05-10 2014-11-11 Marco Benzi Prodotto per l'uso per il trattamento terapeutico di parodontopatie e perimplantiti
CN103611180B (zh) * 2013-11-21 2015-02-18 无锡中科光远生物材料有限公司 一种自粘止血防粘连纤维体的制备方法
JP6794343B2 (ja) 2014-07-11 2020-12-02 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 手術器具および眼組織移植方法
EP3169374B1 (en) 2014-07-14 2022-01-05 University of Utah Research Foundation In situ solidifying complex coacervates and methods of making and using thereof
JP7493961B2 (ja) * 2015-06-22 2024-06-03 クレシロン， インコーポレイテッド 高度に有用な止血用接着性ポリマー足場
CN107708750A (zh) * 2015-06-22 2018-02-16 克里斯伦公司 高度有效的止血粘附性聚合物支架
US10660945B2 (en) 2015-08-07 2020-05-26 Victor Matthew Phillips Flowable hemostatic gel composition and its methods of use
US10751444B2 (en) 2015-08-07 2020-08-25 Victor Matthew Phillips Flowable hemostatic gel composition and its methods of use
CN105030815B (zh) * 2015-08-10 2019-03-15 贵州扬生医用器材有限公司 一种手术冲洗液及其制法
US11065337B2 (en) 2015-12-14 2021-07-20 University of Pittsburgh—of the Commonwealth System of Higher Education Complex coacervate for controlled release and related methods
KR101666792B1 (ko) 2016-02-05 2016-10-17 주식회사 파마리서치프로덕트 핵산 및 키토산을 포함하는 온도감응성 하이드로겔 조성물
WO2017152039A1 (en) 2016-03-04 2017-09-08 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Protection and delivery of multiple therapeutic proteins
CN105860107B (zh) * 2016-04-26 2018-02-09 中南大学 一种过氧化氢响应及具有电化学活性的壳聚糖水凝胶的制备方法
KR101916193B1 (ko) * 2016-08-25 2018-11-07 주식회사 파마리서치프로덕트 핵산 및 키토산을 포함하는 관절강 주사용 조성물
EP3534867B1 (en) 2016-11-07 2025-06-04 Solventum Intellectual Properties Company Medical composition containing guanidinyl-containing polymer(s) and carrageenane(s)
WO2018119320A1 (en) * 2016-12-21 2018-06-28 Cresilon, Inc. Hemostatic compositions with antifibrinolytic agents
CN110121350A (zh) * 2016-12-22 2019-08-13 奥姆里克斯生物药品有限公司 包含阴离子交换剂和钙盐的止血组合物
IL249725A0 (en) * 2016-12-22 2017-03-30 Omrix Biopharmaceuticals Ltd A hemostatic preparation containing an anion exchanger and a calcium salt
JP6939607B2 (ja) * 2017-03-27 2021-09-22 Jsr株式会社 組成物およびその用途
CN108926490B (zh) * 2017-05-25 2021-01-26 南方医科大学南方医院 一种抗凝胃管的制作方法
KR102218427B1 (ko) * 2017-09-20 2021-02-22 차의과학대학교 산학협력단 단백질 약물을 포함하는 코아세르베이트 조성물 및 이를 포함하는 창상 치료제
US11896234B2 (en) 2018-01-26 2024-02-13 Fluidx Medical Technology, Llc Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion
WO2019148137A1 (en) * 2018-01-26 2019-08-01 Polarityte, Inc. Composite-interfacing biomaterial accelerant substrate
RU2675631C1 (ru) * 2018-10-02 2018-12-21 Общество с ограниченной ответственностью "Новые Биомедицинские Решения" Местное гемостатическое средство с повышенной антимикробной активностью
EP3946480A1 (en) * 2019-04-03 2022-02-09 DTech - Società a Responsabilità Limitata Two-component system for the therapeutic treatment of skin lesions and production method thereof
CN110157010B (zh) * 2019-05-05 2021-04-02 上海交通大学 一种基于多糖/聚肽的聚电解质复合物水凝胶止血剂
CN111303453B (zh) * 2020-03-09 2021-06-04 中国海洋大学 一种多重敏感型水凝胶聚合物的制备方法和应用
EP3925636A1 (en) 2020-06-17 2021-12-22 Centre Of Experimental Medicine Slovak Academy Of Sciences Institute Of Experimental Pharmacology Composite membranes containing a smart-released cytoprotectant targeting the inflamed tissue and use thereof
JP2023092390A (ja) * 2021-12-21 2023-07-03 富士フイルム株式会社 止血材組成物
CN115887738B (zh) * 2022-12-16 2024-05-10 湖南师范大学 一种聚丙烯酰胺-壳聚糖/高岭土多孔材料及其制备方法
US12516199B2 (en) 2023-02-15 2026-01-06 Nano And Advanced Materials Institute Limited Transparent, water resistant, antimicrobial and antiviral waterborne coating composition and applications thereof

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206751A (ja) 1982-05-26 1983-12-02 日石三菱株式会社 創傷被覆材
JPS59139310A (ja) 1983-01-31 1984-08-10 Shiseido Co Ltd 乳化組成物
JPH0612993B2 (ja) 1987-08-10 1994-02-23 株式会社クラレ 球状の微生物固定化成形物の製造法
US4956350A (en) * 1988-08-18 1990-09-11 Minnesota Mining And Manufacturing Company Wound filling compositions
FI95207C (fi) 1992-09-14 1996-01-10 Novasso Oy Haavansuojaside
JP3411602B2 (ja) * 1992-10-22 2003-06-03 グンゼ株式会社 キトサンの溶解方法
DE4337152A1 (de) 1993-10-30 1995-05-04 Merck Patent Gmbh Verfahren zur Herstellung von wäßrigen Chitosan-Lösungen und -Gelen
US5670169A (en) 1993-12-20 1997-09-23 E.R. Squibb & Sons, Inc. Wound hydrating gel with novel preservative system and low cytotoxicity
US20020032488A1 (en) 1994-05-13 2002-03-14 Brekke John H. Device for regeneration of articular cartilage and other tissue
US6150581A (en) * 1995-06-07 2000-11-21 United States Surgical Corporation Chitosan/alginate anti-adhesion barrier
US5836970A (en) * 1996-08-02 1998-11-17 The Kendall Company Hemostatic wound dressing
GB2328443B (en) * 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material
CA2317582C (en) 1998-01-06 2009-03-31 Nicholas A. Sceusa A drug dosage form based on the teorell-meyer gradient
JP4241985B2 (ja) * 1998-04-24 2009-03-18 株式会社クラレ 医療用接着材
US6200595B1 (en) 1998-04-24 2001-03-13 Kuraray Co., Ltd. Medical adhesive
JPH11318407A (ja) * 1998-05-19 1999-11-24 Lion Corp 加工食品
WO2000012144A1 (en) 1998-08-31 2000-03-09 Coloplast A/S A composition capable of absorbing fluid
JP4267106B2 (ja) * 1998-10-15 2009-05-27 株式会社クラレ 癒着防止用材料
JP4159682B2 (ja) * 1998-12-22 2008-10-01 株式会社クラレ 止血材
JP4149098B2 (ja) 1999-09-13 2008-09-10 株式会社クラレ 水膨潤性医療用高分子ゲルの製造法及び水膨潤性医療用高分子ゲル
US20030206958A1 (en) 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
US7303814B2 (en) * 2002-02-21 2007-12-04 Encelle, Inc. Immobilized bioactive hydrogel matrices as surface coatings
US7217426B1 (en) * 2002-06-21 2007-05-15 Advanced Cardiovascular Systems, Inc. Coatings containing polycationic peptides for cardiovascular therapy
JP2004041586A (ja) 2002-07-15 2004-02-12 Fujimori Kogyo Co Ltd 生体適合性材料およびその製造方法
US7112713B2 (en) 2003-03-12 2006-09-26 Gelsus Research And Consulting, Inc. Dressing based on the Teorell-Meyer gradient
US7641643B2 (en) 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
EP1718147B1 (en) * 2004-02-23 2012-03-28 Loma Linda University Medical Center Hemostatic agent for topical and internal use
CA2559075A1 (en) 2004-03-11 2005-09-22 Medtrade Products Limited Compositions of alpha and beta chitosan and methods of preparing them
CN101001649B (zh) * 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
EP1799192A2 (en) 2004-07-22 2007-06-27 Allan D. Pronovost Compositions and methods for treating excessive bleeding
WO2007015761A2 (en) * 2005-07-21 2007-02-08 Fmc Biopolymer As Medical devices coated with a fast dissolving biocompatible coating
KR20080067687A (ko) * 2005-11-02 2008-07-21 아이리스 테라퓨틱스, 인코포레이티드 폴리양이온-폴리음이온 착물, 조성물, 및 이의 사용방법
CN100411690C (zh) * 2006-01-17 2008-08-20 武汉理工大学 一种抑菌聚电解质多孔材料的制备方法
WO2007112446A2 (en) 2006-03-28 2007-10-04 University Of Washington Alginate-based nanofibers and related scaffolds
US20070237811A1 (en) * 2006-04-10 2007-10-11 Scherr George H Chitosan wound dressing
ITPD20060203A1 (it) * 2006-05-22 2007-11-23 Univ Degli Studi Trieste Idrogeli di miscele di polisaccaridi per l'ingegneria tissutale e la veicolazione di composti attivi
CN1883721A (zh) * 2006-06-21 2006-12-27 哈尔滨工业大学 共价交联凝胶改性人工植入体的方法
US7935363B2 (en) * 2006-12-12 2011-05-03 Synthasome, Inc. Composite material for tissue repair
NZ579107A (en) 2007-02-19 2012-05-25 Marinepolymer Tech Inc Poly-beta-1-4-n-acetylglucosamine hemostatic compositions and therapeutic regimens
US8216506B2 (en) 2007-06-11 2012-07-10 National University Corporation Kyoto Institute Of Technology Method of processing plant
US20090041858A1 (en) 2007-08-06 2009-02-12 Cao Group, Inc. Haemostatic Compositions Thickened by Polymers Containing Nitrogen Moieties
KR101610268B1 (ko) * 2007-08-28 2016-04-07 애들레이드 리서치 앤드 이노베이션 피티와이 리미티드 외과용 하이드로겔
US20090123509A1 (en) 2007-11-08 2009-05-14 Cory Berkland Biodegradable Colloidal Gels as Moldable Tissue Engineering Scaffolds
US8283384B2 (en) * 2008-01-24 2012-10-09 University Of Utah Research Foundation Adhesive complex coacervates and methods of making and using thereof
JP5757861B2 (ja) * 2008-04-24 2015-08-05 メドトロニック，インコーポレイテッド キトサン−含有保護用組成物
WO2010022132A2 (en) * 2008-08-19 2010-02-25 The Regents Of The University Of Michigan Biocompatible coatings, and methods of making and using the same
CN101463145A (zh) * 2009-01-12 2009-06-24 武汉理工大学 羧甲基壳聚糖/氧化海藻酸钠自交联抗菌水凝胶材料
CN101463144B (zh) * 2009-01-12 2010-12-29 武汉理工大学 羟丙基壳聚糖/氧化海藻酸钠自交联抗菌水凝胶材料的制备方法
WO2010117266A1 (en) 2009-04-06 2010-10-14 Broockeville Corporation N.V. In situ gelling alginate systems
KR101103423B1 (ko) * 2009-09-04 2012-01-06 아주대학교산학협력단 생체 주입형 조직 접착성 하이드로젤 및 이의 생의학적 용도
EP2504039A4 (en) 2009-11-25 2014-07-02 Univ Loma Linda Med HEMOSTATIC TEXTILE BASED ON CHITOSAN
EP2512588A4 (en) * 2009-12-16 2014-06-04 Univ Columbia METHODS, DEVICES AND SYSTEMS FOR ULTRASOUND-RELEASED ON-DEMAND AGGREGATE FREEZING
US8389498B2 (en) 2010-03-26 2013-03-05 Taiwan Textile Research Institute Spinning solution and method for manufacturing biomaterial fibers
US8968362B2 (en) 2010-04-08 2015-03-03 Covidien Lp Coated looped suture
CA2799818A1 (en) * 2010-05-24 2011-12-01 University Of Utah Research Foundation Reinforced adhesive complex coacervates and methods of making and using thereof
CA2807012A1 (en) * 2010-08-05 2012-02-09 Lifebond Ltd. Dry composition wound dressings and adhesives
CN102475691B (zh) 2010-11-30 2014-04-16 中国科学院大连化学物理研究所 海藻酸盐-壳聚糖酰基衍生物微胶囊及其制备和应用
KR101967005B1 (ko) 2011-03-17 2019-04-08 퍼마-픽스 인바이런멘틀 서비시스, 인크. 키토산계 미세다공성 복합물질의 제조 및 이의 응용
JP5835751B2 (ja) 2011-04-01 2015-12-24 珠海奥托沙医薬科技有限公司 医療用吸収性骨創傷止血材及びその調製方法
GB2499359B (en) 2011-10-05 2016-12-28 Univ Of Bolton Polysaccharide fibres for wound dressings
CN109602944A (zh) * 2011-11-13 2019-04-12 克里斯龙公司 原位可交联的聚合物组合物及其方法
WO2013086153A1 (en) 2011-12-09 2013-06-13 Acell, Inc. Hemostatic device
AU2013356930B2 (en) 2012-12-10 2017-01-05 Regenics As Use of egg cellular extracts for skin rejuvenation
US10918765B2 (en) 2013-04-11 2021-02-16 University Of Vermont And State Agricultural College Decellularization and recellularization of whole organs
CN107708750A (zh) 2015-06-22 2018-02-16 克里斯伦公司 高度有效的止血粘附性聚合物支架

Also Published As

Publication number Publication date
JP2018183611A (ja) 2018-11-22
US20140287061A1 (en) 2014-09-25
CA2855347C (en) 2019-03-05
MX366366B (es) 2019-07-05
KR20140090670A (ko) 2014-07-17
IL232330B (en) 2019-06-30
JP2014533181A (ja) 2014-12-11
JP7013336B2 (ja) 2022-01-31
WO2013071235A1 (en) 2013-05-16
JP2021007754A (ja) 2021-01-28
BR112014011442A8 (pt) 2018-01-09
RU2014124157A (ru) 2015-12-27
EP2776068A1 (en) 2014-09-17
US20170266339A1 (en) 2017-09-21
CN103930133A (zh) 2014-07-16
AU2017219007A1 (en) 2017-09-07
CA2855347A1 (en) 2013-05-16
RU2640084C2 (ru) 2017-12-26
US9687584B1 (en) 2017-06-27
IL232330A0 (en) 2014-06-30
US20170157286A1 (en) 2017-06-08
EP2776068A4 (en) 2015-05-20
IN2014CN03524A (es) 2015-10-09
ZA201403166B (en) 2015-11-25
AU2012334982A1 (en) 2014-05-22
US11383005B2 (en) 2022-07-12
WO2013071235A9 (en) 2013-07-18
HK1201734A1 (en) 2015-09-11
CN109602944A (zh) 2019-04-12
MX2014005738A (es) 2014-07-09
RU2017144044A (ru) 2019-02-15
SG11201402279SA (en) 2014-06-27
US20210290817A1 (en) 2021-09-23
SG10201610469QA (en) 2017-02-27
US10850003B2 (en) 2020-12-01
BR112014011442A2 (pt) 2017-05-16

Similar Documents

Publication Publication Date Title
MX2019008051A (es) Composiciones polimericas reticulables in-situ y metodos de las mismas.
WO2014152796A3 (en) Biocompatible and bioabsorbable derivatized chitosan compositions
WO2013061309A3 (en) New a-prp medical device & tissue engineering composition, manufacturing machines and process
WO2019075263A3 (en) Methods and compositions for topical delivery
WO2012008722A3 (ko) 조직 증강용 충전 조성물
WO2009015255A3 (en) Composition and method for improving retention and drainage in papermaking processes by activating microparticles with a promoter-flocculant system
WO2013060769A3 (en) Hemostatic compositions
WO2011126839A3 (en) Compositions and methods for improved retention of a pharmaceutical composition at a local administration site
EP3861982A3 (en) Intracameral implant for treatment of an ocular condition
EP2578622A3 (en) Enhanced oilfield swellable elastomers and methods for making and using same
WO2015023976A3 (en) Selective grp94 inhibitors and uses thereof
MX2015017334A (es) Uso de un polímero de acrilato de 2-octilo como agente de enlace en una composición de recubrimiento.
MX386562B (es) Dispersiones de nanopartículas de lignina y métodos para producir y usar estas.
MX2010004836A (es) Composicion de quitosan.
PH12016500706A1 (en) Smoking article with liquid delivery material
WO2014093489A3 (en) Hydrogel membrane for adhesion prevention
BRPI1011188A2 (pt) composições de liberação dérmica compreendendo complexos de partículas de agente ativo-fosfato de cálcio e métodos para usar as mesmas.
EP2395048A3 (en) Polymers compositions including an antioxidant
NZ603479A (en) Chitosan composition
WO2007144644A3 (en) Extracellular matrix composition
EP2868670A4 (en) MODIFIED CONJUGATE DIENPOLYMER, METHOD FOR THE PRODUCTION OF THE MODIFIED CONJUGATED DIENPOLYME AND RUBBER COMPOSITION WITH THE MODIFIED CONJUGATED DIENPOLYMER
WO2012050879A3 (en) Methods for processing microspheres, microspheres processed thereby, and uses thereof
BR112013025495A2 (pt) massa óssea
WO2012142328A3 (en) Polymer microsphere compositions for localized delivery of therapeutic agents
WO2015130602A3 (en) Sustained release composition using biobased biodegradable hyperbranched polyesters